The new version of this page is scheduled to go live in Q4 2023 and will track new and upcoming treatments in development for Parkinson’s disease (PD).
If you would like to receive an email when this page goes live and resumes tracking treatment-related news, research, clinical trials, and drugs in development (all on one page!), add your email to our announcement list here:
Want early access? Send an email to firstname.lastname@example.org and put “Parkinson’s early access” in the subject line.